1. Home
  2. IMC vs PACB Comparison

IMC vs PACB Comparison

Compare IMC & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IMC Rare Earths Ltd Ordinary Shares

IMC

IMC Rare Earths Ltd Ordinary Shares

N/A

Current Price

$7.91

Market Cap

812.8M

ML Signal

N/A

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

N/A

Current Price

$1.65

Market Cap

696.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IMC
PACB
Founded
2025
2000
Country
Brazil
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
812.8M
696.3M
IPO Year
2026
2010

Fundamental Metrics

Financial Performance
Metric
IMC
PACB
Price
$7.91
$1.65
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $2.74
AVG Volume (30 Days)
63.4K
★ 12.7M
Earning Date
12-01-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $93,468,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$14.03
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.04
52 Week Low
$4.80
$1.07
52 Week High
$12.10
$3.44

Technical Indicators

Market Signals
Indicator
IMC
PACB
Relative Strength Index (RSI) 45.46 36.02
Support Level $6.43 $1.61
Resistance Level $8.30 $1.83
Average True Range (ATR) 1.23 0.22
MACD -0.25 -0.09
Stochastic Oscillator 12.06 1.42

Price Performance

Historical Comparison
IMC
PACB

About IMC IMC Rare Earths Ltd Ordinary Shares

IMC Rare Earths Ltd is a mineral exploration and development company engaged in the exploration, evaluation and development of minerals and metals in Brazil. Its main REE project is the Itarantim Project located in the States of Bahia and Minas Gerais, Brazil.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Share on Social Networks: